Wogonin, a plant flavone, potentiates etoposide-induced apoptosis in cancer cells

Annals of the New York Academy of Sciences

Volumn 1095, Issue , 2007, Pages 521-526

  Lee, Eibai ^a   Enomoto, Riyo ^a   Suzuki, Chie ^a   Ohno, Masataka ^a   Ohashi, Toshinori ^a   Miyauchi, Azusa ^a   Tanimoto, Eriko ^a   Maeda, Kaori ^a   Hirano, Hiroyuki ^a   Yokoi, Toshio ^a   Sugahara, Chiyoko ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

Anticancer effect; Apoptosis; Cancer cell; Etoposide; Wogonin

Indexed keywords

CISPLATIN; DNA FRAGMENT; ETOPOSIDE; FLAVONE DERIVATIVE; FLUOROURACIL; WOGONIN; ANTINEOPLASTIC AGENT; FLAVANONE DERIVATIVE;

ADJUVANT THERAPY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CELL DEATH; CELL STRAIN HL 60; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LUNG CANCER; ANIMAL; ARTICLE; DRUG EFFECT; DRUG POTENTIATION; PATHOLOGY; PROMYELOCYTIC LEUKEMIA; RAT; SCUTELLARIA; T CELL LEUKEMIA;

SCUTELLARIA BAICALENSIS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; DRUG SYNERGISM; ETOPOSIDE; FLAVANONES; HL-60 CELLS; HUMANS; JURKAT CELLS; LEUKEMIA, PROMYELOCYTIC, ACUTE; LEUKEMIA, T-CELL; RATS; SCUTELLARIA;

EID: 34247862144     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1397.056     Document Type: Conference Paper

References (18)

1. SHIEH, D.E., L.T. LIU & C.C. LIN. 2000. Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Res. 20: 2861-2865.
2. LEE, H., Y.O. KIM, H. KIM, et al. 2003. Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J. 17: 1943-1944.
3. CHEN, Y.C., S.C. SHEN, L.G. CHEN, et al. 2001. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochem. Pharmacol. 61: 1417-1427.
4. SON, D., P. LEE, J. LEE, et al. 2004. Neuroprotective effect ofwogonin in hippocampal slice culture exposed to oxygen and glucose deprivation. Eur. J. Pharmacol. 493: 99-102.
5. PIAO, H.Z., S.A. JIN, H.S. CHUN, et al. 2004. Neuroprotective effect of wogonin: potential roles of inflammatory cytokines. Arch. Pharm. Res. 27: 930-936.
6. CHEN, Y.C., S.C. SHEN, W.R. LEE, et al. 2002. Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1. Arch. Toxicol. 76: 351-359.
7. LEE, W.R., S.C. SHEN, H.Y. LIN, et al. 2002. Wogonin and fisetin induce apoptosis in human promyeloleukemic cells, accompanied by a decrease of reactive oxygen species, and activation of caspase 3 and Ca(2+)-dependent endonuclease. Biochem. Pharmacol. 63: 225-236.
8. PARK, S., K.B. HAHM, T.Y. OH, et al. 2004. Preventive effect of the flavonoid, wogonin, against ethanol-induced gastric mucosal damage in rats. Dig. Dis. Sci. 49: 384-394.
9. KIM, H., Y.S. KIM, S.Y. KIM, et al. 2001. The plant flavonoid wogonin suppresses death of activated C6 rat glial cells by inhibiting nitric oxide production. Neurosci. Lett. 309: 67-71.
10. LEE, E., M. MIURA, M. YOSHINARI, et al. 1994. Selective inhibition of dexamethasone-induced apoptosis in rat thymocytes by herbimycin A. Biochem. Biophys. Res. Commun. 202: 128-134.
11. BELINSKY, M.G., Z.S. CHEN, I. SHCHAVELEVA, et al. 2002. Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). Cancer Res. 62: 6172-6177.
12. GUO, A., W. MARINARO, P. HU, et al. 2002. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT). Drug Metab. Dispos. 30: 457-463.
13. ZELCER, N., T. SAEKI, G. REID, et al. 2001. Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3). J. Biol. Chem. 276: 46400-46407.
14. BORST, P., R. EVERS, M. KOOL, et al. 2000. A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer Inst. 92: 1295-1302.
15. CONSEIL, G., H. BAUBICHON-CORTAY, G. DAYAN, et al. 1998. Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein. Proc. Natl. Acad. Sci USA 95: 9831-9836.
16. TAKANAGA, H., A. OHNISHI, S. YAMADA, et al. 2000. Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4. J. Pharmacol. Exp. Ther. 293: 230-236.
17. KITAGAWA, S., T. NABEKURA, T. TAKAHASHI, et al. 2005. Structure-activity relationships of the inhibitory effects of flavonoids on P-glycoprotein-mediated transport in KB-C2 cells. Biol. Pharm. Bull. 28: 2274-2278.
18. VAN ZANDEN, J.J., L. GERAETS, H.M. WORTELBOER, et al. 2004. Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells. Biochem. Pharmacol. 67: 1607-1617.